Compare HCA Health Inc (HCA) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Lowe`s Companies Inc — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Lowe`s Companies Inc trades at $188.88 (market cap $101.85B). The key difference: HCA Health Inc and Lowe`s Companies Inc are close in size by market cap, and Lowe`s Companies Inc pays the higher dividend (2.75%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Lowe`s Companies Inc for 98 Days on average.
| HCA | LOW | |
|---|---|---|
Market Cap | $95.08B | $101.85B |
Volume | 998,787 | 2,370,093 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $287.39 |
52-Week Low | $361.32 | $179.50 |
Typical Hold Time | 76 Days | 98 Days |
Enterprise Value | $145.62B | $140.70B |
Dividend Yield | 0.71% | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Lowe's Companies (LOW) is trading at $181.54, down 1.17% on the day, amid a broader bearish technical trend. The stock shows strong fundamentals with a P/E of 15.35 and consistent earnings beats in recent quarters, though revenue has declined from $96.2B in 2022 to $83.7B in 2025. Recent news highlights the company's innovation with drone delivery partnerships, but the home improvement sector faces headwinds from a sluggish housing market.
The outlook for LOW is mixed; analyst consensus is bullish with a $244.09 price target, but near-term risks include economic pressures on housing and high debt levels. The stock presents a value opportunity for long-term investors given its valuation and dividend history, though volatility may persist until sector conditions improve.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
